Exclusive Summary

• The originator's patent has long expired, ensuring no IP barriers and allowing for immediate commercialization via distribution worldwide.
• functional dyspepsia, nausea, and vomiting affect hundreds of millions globally, ensuring a highly stable and rigid market demand.
• The 10mg formulation perfectly aligns with the optimal safe dosage recommended by the EMA and global clinical guidelines.
• Leveraging China's robust API-to-FDF integrated supply chain, the product offers significant cost advantages and attractive profit margins for local distributors.